Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3452 | SRZN Surrozen, Inc. - Common Stock | 22.57 USD | -1.91% | -10.86% | +4.93% | +161.53% | 262.05 M USD | ||
| 3459 | ACIU AC Immune SA - Common Stock | 2.55 USD | +0.39% | +15.91% | +16.44% | +20.85% | 259.44 M USD | ||
| 3474 | IVVD Invivyd, Inc. - Common Stock | 0.87 USD | -7.45% | +2.35% | -15.53% | +22.54% | 256.31 M USD | ||
| 3480 | NKTX Nkarta, Inc. - Common Stock | 3.52 USD | +4.14% | +22.65% | +45.45% | +98.87% | 251.84 M USD | ||
| 3487 | AVXL Anavex Life Sciences Corp. - Common Stock | 2.69 USD | -0.74% | +3.46% | +1.51% | -73.91% | 249.29 M USD | ||
| 3491 | CHRS Coherus Oncology, Inc. - Common Stock | 1.61 USD | -3.59% | +8.78% | +11.81% | 0.00% | 248.34 M USD | ||
| 3504 | FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.68 USD | -2.39% | 0.00% | +5.44% | -53.88% | 245.21 M USD | ||
| 3515 | KPTI Karyopharm Therapeutics Inc. - Common Stock | 10.64 USD | +5.87% | +11.30% | +22.58% | +10.37% | 241.13 M USD | ||
| 3523 | CDXS Codexis, Inc. - Common Stock | 2.63 USD | +1.15% | +12.88% | +1.15% | -1.87% | 239.06 M USD | ||
| 3533 | OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 3.93 USD | -0.76% | -7.96% | -1.50% | +34.13% | 235.33 M USD | ||
| 3534 | DTIL Precision BioSciences, Inc. - Common Stock | 9.12 USD | -1.41% | +17.22% | +30.85% | +102.67% | 235.32 M USD | ||
| 3550 | TARA Protara Therapeutics, Inc. - Common Stock | 4.12 USD | -3.51% | +8.42% | +0.49% | +35.53% | 231.56 M USD | ||
| 3553 | ARTV Artiva Biotherapeutics, Inc. - Common Stock | 9.32 USD | -1.69% | -5.09% | +37.67% | +124.04% | 230.36 M USD | ||
| 3557 | CLLS Cellectis S.A. - American Depositary Shares | 3.20 USD | -0.62% | +8.84% | +5.26% | +103.82% | 229.60 M USD | ||
| 3566 | CGEN Compugen Ltd. - Ordinary Shares | 2.41 USD | +0.84% | +12.62% | +15.31% | +40.12% | 227.87 M USD | ||
| 3567 | NAUT Nautilus Biotechnology, Inc. - Common Stock | 1.79 USD | +5.92% | -5.79% | -23.50% | +126.58% | 227.47 M USD | ||
| 3573 | KROS Keros Therapeutics, Inc. - common stock | 11.39 USD | -2.23% | +5.95% | +12.77% | -24.57% | 225.43 M USD | ||
| 3575 | RNA Atrium Therapeutics, Inc. - Common Stock | 13.14 USD | -0.76% | -2.59% | +13.28% | -81.32% | 224.77 M USD | ||
| 3579 | NBP NovaBridge Biosciences - American Depositary Shares | 1.94 USD | -3.96% | -2.51% | +20.50% | -56.98% | 223.84 M USD | ||
| 3584 | VYGR Voyager Therapeutics, Inc. - Common Stock | 3.69 USD | -2.38% | +4.53% | +7.27% | -20.65% | 222.95 M USD |
Notícias Biotechnology Stocks
Tarsus Pharmaceuticals adquire iRenix por US$ 75 milhões à vista
TD Cowen reitera recomendação de compra para Prime Medicine após vitória em arbitragem
BofA mantém recomendação de compra para Beam Therapeutics após decisão arbitral
Dinamarca - Ações fecharam o pregão em queda e o Índice OMX Copenhagen 20 recuou 1,33%
‘Por que a CVM não viu isso antes?’
Por que as ações da Beam Therapeutics estão caindo hoje?
Por que as ações da Prime Medicine estão disparando hoje?
Gainers Biotechnology Stocks
TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.76 | +53.55% |
APLMW Apollomics Inc. - Warrant | 0.0161 | +34.17% |
ELTX Elicio Therapeutics, Inc. - Common Stock | 3.51 | +25.36% |
PRME Prime Medicine, Inc. - Common Stock | 4.76 | +19.30% |
SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.50 | +14.84% |
VANI Vivani Medical, Inc. - Common Stock | 1.55 | +14.81% |
CBUS Cibus, Inc. - Class A Common Stock | 1.70 | +13.33% |
CINGW Cingulate Inc. - Warrants | 0.0232 | +11.00% |
Losers Biotechnology Stocks
CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 1.85 | -33.21% |
BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.82 | -21.15% |
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0139 | -17.26% |
JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
ACTU Actuate Therapeutics, Inc. - Common stock | 1.32 | -13.16% |
LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
ONCO Onconetix, Inc. - Common Stock | 0.94 | -12.15% |
MCRB Seres Therapeutics, Inc. - Common Stock | 7.18 | -11.79% |